Study on the Mutation Sites of CSF3R Responsible for the Clonal Advantage of Chronic Neutrophilic Leukemia
Central Asian Journal of Medical Sciences · 2016
DOI: 10.24079/cajms.2016.01.007 ↗Kurz gefasst
Fachartikel in der Zeitschrift Central Asian Journal of Medical Sciences, 2016. Verfasst von Otgonbat Altangerel und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Objectives
Chronic neutrophilic leukemia (CNL) is a rare, but distinct, entity within myeloproliferative neoplasms, characterized by splenomegaly, sustained mature neutrophilia, and absence of the Philadelphia chromosome. In 2013, oncogenic mutations in colony stimulation factor 3 receptor (CSF3R) were identified in a majority of patients with CNL and it was demonstrated that their downstream signaling was sensitive to known kinase inhibitors. This discovery was then validated with the demonstration of 100% CSF3R mutational frequency (predominately CSF3R-T618I) in strictly CNL as defined by the World Health Organization (WHO). In September 2012, a 67-year-old Chinese man was admitted to the First Central Clinical College of Tianjin Medical University (Tianjin, China) and presented as a case who had fulfilled the WHO diagnostic criteria for CNL with a oncogenic mutation in CSF3R-T618I and also an unreported novel mutation site of CSF3R-H54A Thus, we sought to determine if CSF3R-FL, CSF3R-T618I, CSF3R-H54A mutations have some significance on the molecular pathogenesis of CNL.
Methods
In this study, three main experiments were used including plasmid construction, lentiviral packaging system, and Mouse Colony-Forming Unit Assays Using MethoCult™.
Results
The establishment of these three experiments was completed successfully. We confirmed the transformation capacity of the CSF3R mutations, especially that CSF3R-T618I was higher than CSF3R-FL Conclusion: This result demonstrates that T618I mutation of CSF3R conferred the clonal advantage of CNL leukemia cells.
Zitieren
APA
Altangerel, O., Zhao, M. F., & Mao, W. R. (2016). Study on the Mutation Sites of CSF3R Responsible for the Clonal Advantage of Chronic Neutrophilic Leukemia. Central Asian Journal of Medical Sciences. https://doi.org/10.24079/cajms.2016.01.007
Vancouver
Altangerel O, Zhao MF, Mao WR. Study on the Mutation Sites of CSF3R Responsible for the Clonal Advantage of Chronic Neutrophilic Leukemia. Central Asian Journal of Medical Sciences. 2016. doi:10.24079/cajms.2016.01.007
BibTeX
@article{Altangerel2016,
author = {Altangerel, Otgonbat and Zhao, Ming Feng and Mao, Wu Ri},
title = {Study on the Mutation Sites of CSF3R Responsible for the Clonal Advantage of Chronic Neutrophilic Leukemia},
journal = {Central Asian Journal of Medical Sciences},
year = {2016},
doi = {10.24079/cajms.2016.01.007}
}
EUVIMED